Skip to content
Biodatica
Start free

Investigator

Arkadij Elizarov

TRACE-ABILITY, INC. · funded by NIAID, NIA

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$3.5M

Summed across those awards.

First award
Feb 1, 2021

Latest Jan 15, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R44

    Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform.

    $1.0M

    Jan 15, 2024NIAIDTRACE-ABILITY, INC.NIH RePORTER · 11010813 (opens the source filing in a new tab)

  2. R44

    Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform.

    $1.0M

    Jan 15, 2024NIAIDTRACE-ABILITY, INC.NIH RePORTER · 11300991 (opens the source filing in a new tab)

  3. R44

    Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.

    $1.5M

    Feb 1, 2021NIATRACE-ABILITY, INC.NIH RePORTER · 11163546 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources